CHOICE for Veterans Act of 2025
Summary
The CHOICE for Veterans Act of 2025 (HR3132) is awaiting floor action after being reported out of committee. This bill expands fee agreements for VA benefits claims, which is expected to improve claims efficiency and reimbursement rates for healthcare providers serving veterans. Companies like HCA Healthcare ($HCA), Universal Health Services ($UHS), Labcorp Holdings ($LH), and Quest Diagnostics ($DGX) are positioned to benefit from these operational improvements.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The CHOICE for Veterans Act of 2025 (HR3132) has cleared committee and is awaiting a House floor vote, indicating strong legislative momentum.
- 2.The bill allows fee agreements for VA benefits claims, which is expected to streamline the claims process and improve reimbursement efficiency for healthcare providers.
- 3.Companies like HCA Healthcare ($HCA), Universal Health Services ($UHS), Labcorp Holdings ($LH), and Quest Diagnostics ($DGX) are positioned to benefit from more reliable and timely VA reimbursements.
- 4.Despite recent market declines for these healthcare stocks, the bill provides a structural positive impact on their revenue cycle management for veteran patients.
Market Implications
The passage of HR3132 would create a bullish structural shift for healthcare providers serving veterans. By enabling fee agreements for VA claims assistance, the bill improves the efficiency and success rate of benefit claims, directly translating to more reliable and potentially higher reimbursement for services provided by companies like HCA Healthcare ($HCA), Universal Health Services ($UHS), Labcorp Holdings ($LH), and Quest Diagnostics ($DGX). While current market trends show recent declines for these tickers, this legislative development offers a long-term operational improvement that could support future revenue stability and growth in their VA-related business segments.
Full Analysis
The CHOICE for Veterans Act of 2025, HR3132, was reported out of the House Committee on Veterans' Affairs on May 6, 2025, and is now awaiting floor action. The bill was introduced on May 1, 2025, and referred to the committee, where it underwent consideration and mark-up before being ordered to be reported. This indicates active legislative momentum for the bill.
The core mechanism of HR3132, as detailed in Section 3, is to amend title 38, United States Code, to permit fee agreements for services rendered in the preparation, presentation, and prosecution of initial and supplemental claims for benefits under laws administered by the Secretary of Veterans Affairs. This legislative change does not authorize new direct funding but rather modifies the regulatory framework for how veterans can seek assistance with their claims and how those assistance providers are compensated. By allowing fee agreements, the bill aims to incentivize more robust and professional claims assistance, which in turn should lead to more accurate and timely claim submissions to the VA.
The structural winners are healthcare providers that serve veterans, as improved claim submissions directly translate to more efficient and potentially higher reimbursement rates from the VA. This positively impacts their revenue cycle management. Companies such as HCA Healthcare ($HCA), Universal Health Services ($UHS), Labcorp Holdings ($LH), and Quest Diagnostics ($DGX) are direct beneficiaries due to their significant operations in hospital services, behavioral health, and diagnostic testing, all of which are utilized by veterans. The bill's sponsor, Rep. Jack Bergman (R-MI-1), a Republican from Michigan, along with 51 cosponsors, indicates broad support for this measure.
Recent market data shows a general downward trend for these healthcare providers. As of April 28, 2026, HCA Healthcare ($HCA) is at $430.45, down 8.68% over 7 days and 8.77% over 30 days. Universal Health Services ($UHS) is at $163.81, down 9.36% over 7 days and 10.99% over 30 days. Labcorp Holdings ($LH) is at $259.76, down 4.72% over 7 days and 1.68% over 30 days. Quest Diagnostics ($DGX) is at $195.05, down 4.39% over 7 days and 0.24% over 30 days. Despite these recent declines, the passage of HR3132 would provide a structural tailwind by improving the efficiency of VA reimbursements, which could mitigate future downward pressure or support recovery.
Regarding the legislative timeline, the bill has cleared committee and is awaiting a vote on the House floor. If passed by the House, it would then proceed to the Senate for consideration. There are no direct presidential actions that conflict with or amplify this specific bill, as the 'Accelerating Medical Treatments for Serious Mental Illness' Executive Order focuses on psychedelic-based therapies, which is a distinct area from VA claims processing.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
What the bill does
Amends title 38, United States Code, to allow fee agreements for initial and supplemental claims for VA benefits, as per Section 3 of HR3132.
Who must act
Veterans Affairs (VA) benefits claimants and legal/claims assistance service providers.
What happens
Increases revenue opportunities for legal and claims assistance services, leading to more efficient and potentially higher quality claim submissions for VA benefits. This improves the likelihood and speed of reimbursement for healthcare providers.
Stock impact
HCA Healthcare, as a major hospital operator, will experience improved reimbursement rates and reduced administrative burden for services provided to veterans, positively impacting its revenue cycle management for VA patients. This directly affects HCA's patient revenue from a significant demographic.
What the bill does
Amends title 38, United States Code, to allow fee agreements for initial and supplemental claims for VA benefits, as per Section 3 of HR3132.
Who must act
Veterans Affairs (VA) benefits claimants and legal/claims assistance service providers.
What happens
Increases revenue opportunities for legal and claims assistance services, leading to more efficient and potentially higher quality claim submissions for VA benefits. This improves the likelihood and speed of reimbursement for healthcare providers.
Stock impact
Universal Health Services, a provider of hospital and behavioral health services, will see enhanced and more predictable reimbursement for services rendered to veterans. This streamlines its revenue collection process and improves financial stability related to VA patients.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
SUPPORT for Patients and Communities Reauthorization Act of 2025
To amend title XVIII of the Social Security Act to prevent hospitals or skilled nursing facilities that are owned by certain firms from participating in the Medicare program.
ASAP Act
Veterans’ Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025
Physician and Patient Safety Act
SPREZZATURA MANAGEMENT CONSULTING, LLC: $23.2M Department of Veterans Affairs Contract
Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →